These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 14709693)

  • 21. Left Chylothorax Without Ascites in a Liver Transplant Patient.
    McCormick BJ; Archana R
    Cureus; 2024 May; 16(5):e60996. PubMed ID: 38916011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current management of refractory ascites in patients with cirrhosis.
    Zhao R; Lu J; Shi Y; Zhao H; Xu K; Sheng J
    J Int Med Res; 2018 Mar; 46(3):1138-1145. PubMed ID: 29210304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
    Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
    Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chylous ascites and chylothorax. Presenting manifestation of pancreatic carcinoma.
    Patel RM; Purow E
    N Y State J Med; 1982 Mar; 82(3):349-51. PubMed ID: 6953339
    [No Abstract]   [Full Text] [Related]  

  • 26. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
    Garcia-Tsao G
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
    Strunk H; Marinova M
    Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chylous ascites and TIPS].
    Vargas L; Lobo S; Agar S; Rodríguez A; Soto JR
    Rev Med Chil; 1997 Feb; 125(2):220-1. PubMed ID: 9430944
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chylous ascites in cirrhosis. Retrospective study of 20 cases].
    Sultan S; Pauwels A; Poupon R; Lévy VG
    Gastroenterol Clin Biol; 1990; 14(11):842-7. PubMed ID: 2177427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of ascites in children.
    Lane ER; Hsu EK; Murray KF
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1281-92. PubMed ID: 26325252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
    Tan HK; James PD; Sniderman KW; Wong F
    J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dysfunction of a TIPS (transjugular intrahepatic porto-systemic shunt) and chylous ascites].
    Rovira E; Molés JR; Hinojosa J; Primo J; Gonzalvo F; Albert A
    Rev Esp Enferm Dig; 1997 Jun; 89(6):475-7. PubMed ID: 9303612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
    Ainsworth MA; Nielsen OH
    Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
    [No Abstract]   [Full Text] [Related]  

  • 34. Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Refractory Transudative Chylothorax due to Liver Cirrhosis.
    Khaliq MF; Noorani MM; Chowdhry M; Mohamed H; Koirala A
    Case Rep Med; 2020; 2020():2581040. PubMed ID: 32089702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transjugular intrahepatic portosystemic shunt in cavernomatous portal vein occlusion.
    Brountzos EN; Malagari K; Alexopoulou E; Nikolaou VE; Panagiotou I; Argyriou P; Efstathopoulos E; Kelekis DA
    Hepatogastroenterology; 2004; 51(58):1168-71. PubMed ID: 15239270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Post-surgical lymphocutaneous fistula, chylous ascites and chylothorax--infrequent but serious complications: etiology, diagnosis and therapeutic options].
    Benedix F; Lippert H; Meyer F
    Zentralbl Chir; 2007 Dec; 132(6):529-38. PubMed ID: 18098081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of refractory ascites in a child with transjugular intrahepatic portosystemic shunt.
    Lee WS; McKiernan PJ; de Ville de Goyet JV; Tanner MS; John PR
    Acta Paediatr; 2001 Nov; 90(11):1352-5. PubMed ID: 11808914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chylothorax and chylous ascites due to malignant lymphoma.
    Oosterbosch L; Leloup A; Verstraeten P; Jordens P
    Acta Clin Belg; 1995; 50(1):20-4. PubMed ID: 7725834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.